Recall Radar
All recallsMedicine & devices

Cetirizine Hydrochloride Tablets USP 5 mg, 100-count bottle, Manufactured by: Unique Pharmaceuticals Labs, (A Div. of J.B. Chemicals & Pharmaceuticals, Ltd.), Mumbai 400 030, Indi…

Cross Contamination with Other Products: Customer complaints for appearance of discolored tablets and red dots observed on Cetirizine Hydrochloride Tablets USP 5 mg. Determined to be Ranitidine.

Class I Medicine & devices FDA July 29, 2026 Reached Texas
Read the official FDA notice →

What to do

Stop using the product and check it against the description above. This recall is in the most serious category, meaning the agency believes it can cause serious injury or death — don't finish the package or use up what's left. If you or a family member has already been affected, keep the packaging and the lot code — they're what a claim rests on later.

Details

Recalling company
JB Chemicals and Pharmaceuticals Ltd — Mumbai, N/A
Severity
Class I — serious
Reported
July 29, 2026
Quantity
34,020 100-count bottles.
Recall number
D-0732-2026
Status
Ongoing
Source
FDA

Where it went

Nationwide in the USA

Other medicine & devices recalls

See every current recall on the live dashboard →